CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 3, 2023--

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 10:30 a.m. PT in San Francisco, CA.

A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20230103005159/en/

CONTACT: Investors

Helen Rubinstein

315-382-3979

helen.rubinstein@sagerx.comMedia

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH NEUROLOGY OTHER HEALTH GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Sage Therapeutics, Inc.

Copyright Business Wire 2023.

PUB: 01/03/2023 06:30 AM/DISC: 01/03/2023 06:30 AM

http://www.businesswire.com/news/home/20230103005159/en